Ask Our Experts March 7, 2024 Early cancer detection is paramount in the relentless battle against cancer Recent findings from the American Cancer Society’s latest 2024 Cancer Statistics report paint a complex picture: while overall cancer mortality rates are on a promising decline, the landscape is marred by a … Read More
Case Studies March 7, 2024 PHM’s Evidence-Based Approach Reduces Treatment Uncertainty for Our Patient with Breast Cancer Many cancer patients are faced with deep, personal decisions about what treatment path will be right for them. There are many factors to consider, including the likelihood that the cancer may come … Read More
Podcasts February 15, 2024 Securing top-quality medical care for family members with Leslie Michelson Leslie Michelson, Chairman and Co-Founder of PHM, has over five decades of experience navigating our fragmented healthcare systems for individuals, family offices, and employers. In the Family Office Exchange podcast with FOX CEO Peter Moustakerski, Leslie challenges the misconception that access and wealth guarantee the right healthcare. He shares strategies and tools from his best-selling book, "The Patient’s Playbook." Read More
News February 14, 2024 The future of precision cancer therapy might be to try everything This article, published by Nature, references PHM’s case study, published in Frontiers in Oncology, in partnership with SEngine Precision Medicine. The case highlights the use of SEngine’s cutting-edge molecular profiling technology, the … Read More
Published Research February 12, 2024 Pancreatic Cancer Treatment Option Study Published Pancreatic cancer is notoriously difficult to treat. At PHM we deploy comprehensive molecular profiling to identify potential treatment options for all patients with cancer. Along with our partners at Guardant Health, we … Read More
Published Research January 17, 2024 Personalized Testing Extends Stable Disease for Rare Ovarian Cancer Ovarian cancers are the second most common cancer of the female reproductive system and are associated with the highest risk of cancer-related death, with most women presenting with advanced-stage disease. A recent … Read More
